跳至主要内容
临床试验/NCT02066961
NCT02066961已完成不适用

A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk for Poor Clinical Outcomes After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-Resistant Prostate Cancer and Men With Metastatic Prostate Cancer at Initial Diagnosis

Astellas Pharma Global Development, Inc.1 个研究点 分布在 1 个国家目标入组 1,533 人开始时间: 2013年12月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,533
试验地点
1
主要终点
Patterns of disease management

研究概览

简要总结

The purpose of this study is to describe patterns in disease management and to describe clinical outcomes, as well as to identify factors influencing physician treatment decisions including reason(s) for treatment choices and trigger(s) for treatment changes and to document healthcare resource utilization used to manage treatment-related complications.

详细描述

Each subject will be followed from the time of enrollment for a minimum of 3 years and a maximum of up to 6 years or until death, whichever comes first.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • Diagnosis of prostate adenocarcinoma
  • Will receive a new intervention at the time of study entry, for the treatment of:
  • Biochemical failure after initial curative-intent surgery (radical prostatectomy) or radiotherapy (external-beam radiation therapy, brachytherapy, or both) and a PSA doubling time of one year or less or a confirmed PSA of ≥ 50 ng/mL (2 consecutive values) within 6 months prior to study entry; or
  • Castration-resistant prostate cancer; or
  • Metastatic prostate cancer at initial diagnosis of prostate cancer

排除标准

  • Prior treatment of metastatic castration-resistant prostate cancer with systemic chemotherapy
  • Life expectancy of <1 year due to comorbidities

结局指标

主要结局

Patterns of disease management

时间窗: up to 72 months

Description of disease assessment methods, physician referral patterns and treatments

Clinical outcomes

时间窗: up to 72 months

Evidence of disease progression and development of symptomatic disease

次要结局

  • Factors influencing physician treatment decisions(up to 72 months)
  • Documentation of healthcare resource utilization used to manage treatment-related complications(up to 72 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验